Literature DB >> 3198504

Inhibitory effect of new antibiotic, pradimincin A on infectivity, cytopathic effect and replication of human immunodeficiency virus in vitro.

A Tanabe1, H Nakashima, O Yoshida, N Yamamoto, O Tenmyo, T Oki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3198504     DOI： 10.7164/antibiotics.41.1708

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  10 in total

1.  Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus.

Authors:  Jan Balzarini; Kristel Van Laethem; Dirk Daelemans; Sigrid Hatse; Antonella Bugatti; Marco Rusnati; Yasuhiro Igarashi; Toshikazu Oki; Dominique Schols
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

2.  Effects of succinylated concanavalin A on infectivity and syncytial formation of human immunodeficiency virus.

Authors:  T Matsui; S Kobayashi; O Yoshida; S Ishii; Y Abe; N Yamamoto
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

3.  Characterization and carbohydrate specificity of pradimicin S.

Authors:  Syed Shahzad-ul-Hussan; Rodolfo Ghirlando; Cajetan I Dogo-Isonagie; Yasuhiro Igarashi; Jan Balzarini; Carole A Bewley
Journal:  J Am Chem Soc       Date:  2012-07-17       Impact factor: 15.419

4.  Assays to detect and characterize human immunodeficiency virus type 1 (HIV-1) receptor antagonists, compounds that inhibit binding of the HIV-1 surface glycoprotein, gp120, to the CD4 receptor on human T lymphocytes.

Authors:  J Clancy; A Tait-Kamradt; J Petitpas; M Manousos; P R McGuirk; T Subashi; P Watts; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

5.  The phthalocyanine prototype derivative Alcian Blue is the first synthetic agent with selective anti-human immunodeficiency virus activity due to its gp120 glycan-binding potential.

Authors:  Katrien O François; Christophe Pannecouque; Joeri Auwerx; Virginia Lozano; Maria-Jésus Pérez-Pérez; Dominique Schols; Jan Balzarini
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

6.  Microwave-assisted synthesis of novel 2H-chromene derivatives bearing phenylthiazolidinones and their biological activity assessment.

Authors:  Islam H El Azab; Mohamed M Youssef; Mahmoud A Amin
Journal:  Molecules       Date:  2014-11-26       Impact factor: 4.411

Review 7.  Potential of carbohydrate-binding agents as therapeutics against enveloped viruses.

Authors:  K O François; J Balzarini
Journal:  Med Res Rev       Date:  2010-06-23       Impact factor: 12.944

8.  The carbohydrate-binding plant lectins and the non-peptidic antibiotic pradimicin A target the glycans of the coronavirus envelope glycoproteins.

Authors:  F J U M van der Meer; C A M de Haan; N M P Schuurman; B J Haijema; M H Verheije; B J Bosch; J Balzarini; H F Egberink
Journal:  J Antimicrob Chemother       Date:  2007-08-18       Impact factor: 5.790

9.  Antiviral activity of carbohydrate-binding agents against Nidovirales in cell culture.

Authors:  F J U M van der Meer; C A M de Haan; N M P Schuurman; B J Haijema; W J Peumans; E J M Van Damme; P L Delputte; J Balzarini; H F Egberink
Journal:  Antiviral Res       Date:  2007-05-21       Impact factor: 5.970

Review 10.  Molecular architecture and therapeutic potential of lectin mimics.

Authors:  Yu Nakagawa; Ito Yukishige
Journal:  Adv Carbohydr Chem Biochem       Date:  2012       Impact factor: 12.200
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.